Board Meeting Details

  • Meeting Date: Monday, July 13, 2026
  • Location: Registered Office of the Company
  • Primary Agenda: To consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the First Quarter ended June 30, 2026 (Q1 FY27)

Trading Window Restrictions

  • Trading window closure effective for all Directors, Promoters, Designated Employees, and Specified Connected Persons of the Company
  • Closure period: Until July 15, 2026
  • Reason: Precautionary measure in view of the board meeting and results announcement

Financial Impact

Financial impact not quantified in this disclosure. The meeting is scheduled to review and approve financial results, but specific figures are not provided in this intimation.